Comprehensive pharmacist-managed oral chemotherapy monitoring, education, and adherence program
|
|
- Ruth Barton
- 8 years ago
- Views:
Transcription
1 Comprehensive pharmacist-managed oral chemotherapy monitoring, education, and adherence program Becky Fahrenbruch, Pharm D, BCOP Fairview Maple Grove Medical Center Oncology Infusion Pharmacy Maple Grove, Minnesota Faculty Disclosures Becky has participated on advisory boards for Genetech, Lilly and Taiho. She is a speaker for Grifols. Objectives Explain the steps in developing a comprehensive oral chemotherapy program Discuss the pharmacist involvement and function in managing patients on oral chemotherapy Describe technician workflow in assisting patients on oral chemotherapy Summarize result of a retrospective review conducted at a large health system regarding pharmacist management of oral chemotherapy Why a Pharmacy Driven Program? Oncology Medical Director sought a system-wide pharmacist managed program Pharmacist group was developed to define new process Retrospective internal review (MD managed patient monitoring): 54% (cycle 1) 39.2% (cycle 2) 35.4% (cycle 3) Developing a Comprehensive Oral Program EPIC protocol development for oral regimens Patient educational materials Drug information sheets (including ASCO QOPI measures) Adherence calendars Guidelines for monitoring oral chemotherapy (drug specific) Workflow process for pharmacists and technicians Education of health care staff Patient Education Materials Patient Education Packet Fairview drug education Coping with. (diarrhea, n/v, neutropenia etc) Safe Handling of Oral Chemotherapy Medication Oral Chemotherapy Management Program Overview Cancer Clinic Pharmacy Liaison Services Overview and contact information Medication calendar if needed Patient satisfaction survey 1
2 Which of the following is helpful when developing an oral chemotherapy program?(objective 1) a)patient educational materials b)drug specific monitoring guidelines c)workflow for pharmacy staff d)all of the above Professional Education Pharmacist: Oral Chemo Process Modules 1:How to Verify/Check an Oral Chemo Order 2: How to Teach the Patient About Oral Chemotherapy 3: Monitoring the Patient 4: Plan for Monitoring Patient Adherence Technician Liaison Training Provider Oral Chemotherapy Management Program Workflow Overview Oral Chemotherapy Management Program Intro for Providers Provider 2
3 Pharmacist Management Pharmacist Patient Education Pharmacist Monitoring Pharmacist Monitoring Drug information & Monitoring Therapy Ends 3
4 Which of the following steps was included in the pharmacist managed oral oncology program? (Objective 2) a) Documentation done by lab technician b) Nurse in the exam room during education c) Oncologist education on oral chemotherapy d) Call back to patient after 3-5 days Financial Issue Financial burden of oral chemotherapies 1 in 10 patients abandoned their first prescription for an oral chemotherapy agent One quarter of patients were not able to receive their first oral chemotherapy and followed up with a second, potentially causing an unnecessary delay in treatment 1 in 4 patients filling prescriptions with cost-sharing amounts over $500 abandoned the prescription and did not receive another within 90 days Streeter SB, et al. Am J Manage Care. 2011;17(Suppl 5): Pharmacy Technician Pharmacy Technician Workflow Meet patient and discuss role Release e-scribe prescription to retail pharmacy to determine coverage and additional information: Participating pharmacy as determined by insurance Prior Authorization Coverage appeals Pharmacy Technician Workflow Determine if financial assistance is needed Discussion with patient Research options for financial assistance Private vs. Public Insurance Private Insurance or No Insurance Manufacturer sponsored assistance programs Public Insurance Co-pay assistance programs through various private foundations Obtain medication Sent to patient s home Available for pick up Pharmacy Technician Workflow Financial Assistance Where to start*? Criteria to be eligible Completion and submission of application Obtaining funds *Resources for pharmacist 4
5 Financial Assistance Foundations* Which of the following is a financial assistance foundation? (Objective 3) a) NeedyMeds b) Fairview c) Healthwell d) Preferred One *Resources for pharmacist Fairview Program Our program began system wide within Fairview in March 2013 Multi-site analysis designed to assess the impact of a pharmacist-managed oral chemotherapy program Primary outcome is adherence to recommended monitoring parameters Secondary outcomes including appropriate patient education, medication regimen adherence, and patient satisfaction. Design 238 ambulatory cancer patients receiving treatment at an outpatient cancer clinic Retrospective data was collected for 119 patients in a historical group (pre-implementation of a pharmacistmanaged oral chemotherapy program) 119 patients in an intervention group (post-implementation) Exclusion concomitant intravenous therapy counseling not done by a pharmacist enrollment on a study insufficient data for collection Medication # included # excluded Capecitabine Sorafenib 27 8 Imatinib Everolimus Sunitinib Temozolomide Abiraterone Erlotinib Nilotinib 5 3 Vemurafenib 4 1 Pazopanib Exclusion reasons: Concurrent IV therapy, RPh intervention (historical), not a new start to therapy (intervention), pt never started, incomplete records, study patient Results Adherence to Monitoring Parameters for Historical and Intervention Groups 90 Percentage Cycle 1 Cycle 2 Cycle 3 -P value < for all cycles MD Driven RPh Driven 5
6 Results Patient Education for Historic and Intervention Groups Education Physician Pharmacist P-value Parameter Documented Documented Name of Agent 94.12% % Dose 73.95% % < Indication 92.44% % Schedule 77.31% % < Lab/Toxicity 31.09% % < Monitoring Frequency of 55.46% 99.16% < Office Visits Safe Handling 0% 96.64% < Missed Dose 0.84% 95.80% < Food/Drug 4.20% % < Interactions Side Effects 73.95% 99.16% < Contact 10.92% 99.16% < Information Adherence Based on patient report and assessed in the intervention group Each encounter following the initiation of therapy, patients were asked How many doses have you missed in the past two weeks? Adherence was reported as a percentage of doses taken during each two week interval Adherence will be compared with the commonly accepted definition of adherence, which is greater than or equal to 80%. Results Reported medication adherence as 99.59% (cycle 1), 99.86% (cycle 2), and 99.49% (cycle 3). Average overall 99.6% Patient Survey Nine 4-point Likert scale questions (strongly agree, agree, disagree, and strongly disagree) online or paper 1) I know when to take my medicine (ex: when and how many times a day) 2) I know how to take my medicine (ex: with or without food) 3) I know what to do if I miss a dose 4) I know about some of my medicine s possible side effects 5) I know who to call if I have questions about my medicine 6) The pharmacist listened to my concerns 7) The clinic pharmacist answered my questions 8) I was happy with the amount of time the pharmacist spent with me 9) I was happy with the amount of information the pharmacist gave me Survey Results Overall program scored 3.78 out of a possible 4.0 points 100% of respondents also agree the pharmacists listened to their concerns and were happy with the time the pharmacist spent with them and the information provided Patients who returned surveys, all agreed they know: When and how to take their medication What to do if they miss a dose Understand possible side effects Know who to call if they have questions Program Success In 2015 to date more than 4 million dollars in financial assistance has been obtained for Fairview patients Plan for publication Limitations Retrospective review, which introduces the possibility of observer bias Did not reaching adequate power due to the small number of patients collected in the historic group Patient self-report for medication adherence 6
7 Which of the following medications were included in analysis of the program discussed? (Objective 4) a) Capecitabine b) Thalidomide c) Afatinib d) Regorafenib Conclusion A variety of resources are needed when developing a comprehensive oral chemotherapy pharmacy management program Pharmacist and technician can have specific roles in managing oral chemotherapy patients Medication assistance programs exist to cover high outof-pocket costs for oral chemotherapy agents After implementing the program, adherence to monitoring for the first three cycles was statistically significant at 75.2%, 77.1%, and 75.3% References Aisner J. Overview of the changing paradigm in cancer treatment: oral chemotherapy. Am J Health-Syst Pharm. 2007; 64: S4-S7. Schwartz RN, Eng KJ, Frieze DA, et al. NCCN Task force report: specialty pharmacy. J Natl Compr Canc Netw. 2010; 8(suppl 4): S1-S12. Mosely WG, Nystrom JS. Dispensing oral medications: why now and how? Community Oncology. 2009; 6: Hansen LA. Best practices in maximizing adherence to cancer therapy. The Oncology Pharmacist. Accessed June 3, Weingart S, Flug J, Brouillard D, et al. Oral chemotherapy safety practices at US cancer centres: questionnaire survey. BMJ. 2007; 334: 407. Simchowitz, B, Shiman L, Spencer J, et al. Perceptions and Experiences of Patients Receiving Oral Chemotherapy. Clinical Journal of Oncology Nursing. 2010; 14: Regnier-Denois V, Poirson J, Nourissat A, et al. Adherence with Oral Chemotherapy: Results from a Qualitative Study of the Behaviour and Representations of Patients and Oncologists. European Journal of Cancer Care. 2011; 20: Mancini R, Kaster L, Vu B, Modlin J, Wilson D. Implementation of a pharmacist-managed interdisciplinary oral chemotherapy program in a community cancer center. J Hematol Oncol Pharm. 2011; 1(2): Simons S, Ringsdorf S, Braun M, et al. Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary care. Support Care Cancer. 2011; 19: Resources for Pharmacists rarediseases.org American Society of Clinical Oncology. The Quality Oncology Practice Initiative. Accessed June 15th,
Patients diagnosed with cancer require timely access to appropriate
Patient and Plan Characteristics Affecting Abandonment of Oral Oncolytic Prescriptions Sonya Blesser Streeter, MPP, MPH; Lee Schwartzberg, MD; Nadia Husain, ScM; and Michael Johnsrud, PhD Objective: To
More informationImproving Electronic Oral Chemotherapy Prescription: Can We Build a Safer System?
Focus on Quality Original Contribution Improving Electronic Oral Chemotherapy Prescription: Can We Build a Safer System? By Saul N. Weingart, MD, PhD, Thea Mattsson, MD, Junya Zhu, RN, MS, Lawrence N.
More informationMedication Safety of Five Oral Chemotherapies: A Proactive
Original Contribution Medication Safety of Five Oral Chemotherapies: A Proactive Risk Assessment By Saul N. Weingart, MD, PhD, Justin Spencer, MPA, Stephanie Buia, MBA, Deborah Duncombe, MHP, Prabhjyot
More informationSpecialty Pharmacy Definition
Isn t All of Special? Developing Services Presented to: 2015 ICHP Annual Meeting Presented on: September 10, 2015 Presented by: Lana Gerzenshtein, Pharm.D., BCPS The speaker has no conflicts of interest
More informationOncology Medical Home: Strategies for Changing What and How We Pay for Oncology Care
Oncology Medical Home: Strategies for Changing What and How We Pay for Oncology Care John Fox, MD MHA Senior Medical Director Priority Health 1 Cancer Care is the Leading Edge of Medical Cost Trend for
More information10/31/2014. Medication Adherence: Development of an EMR tool to monitor oral medication compliance. Conflict of Interest Disclosures.
Medication Adherence: Development of an EMR tool to monitor oral medication compliance Donna Williams, RN PHN Carol Bell, NP MSN Andrea Linder, RN MS CCRC Clinical Research Nurses Stanford University SOM
More informationHealth Insurance and Cancer Drug Reimbursement
Quality health plans & benefits Healthier living Financial well-being Intelligent solutions Health Insurance and Cancer Drug Reimbursement Michael Kolodziej, M.D., FACP National Medical Director, Oncology
More informationOral Oncology Treatment Regimens and the Role of Medication Therapy Management on Patient Adherence and Compliance
Oral Oncology Treatment Regimens and the Role of Medication Therapy Management on Patient Adherence and Compliance Oral Cancer Care Therapies: The Opportunity and The Challenge Chemotherapy used to treat
More informationThe experience at one institution by Ketan Patel, RPh, MBA, and Patrick Grusenmeyer, ScD, FACHE
The experience at one institution by Ketan Patel, RPh, MBA, and Patrick Grusenmeyer, ScD, FACHE T he primary function of pharmacy is to prepare medications and to improve patient safety by advising physicians,
More informationUNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014 Department Name: Department of Pharmacy Department Director: Steve Rough, MS,
More informationNorth Carolina Medicaid Special Bulletin
North Carolina Medicaid Special Bulletin An Information Service of the Division of Medical Assistance Please visit our Web site at www.ncdhhs.gov/dma July 2007 ATTENTION: All Providers Notice of Change
More informationUS Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety Standards
Original Contribution US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety Standards By Saul N. Weingart, MD, PhD, Justin W. Li, BA, Junya Zhu, RN, MS, MA,
More informationNovel Opportunities for Engagement Utilizing in House Pharmacy Services
Novel Opportunities for Engagement Utilizing in House Pharmacy Services Ray Bailey, BSPharm RPh Director of Pharmacy, FCS Rx to Go Pharmacy rbailey@flcancer.com Angel Aslo, Pharm.D. Director of Pharmacy,
More informationIntroduction to Medication Management Systems, Inc. Comprehensive Medication Therapy Management Solutions
Introduction to Medication Management Systems, Inc. Comprehensive Medication Therapy Management Solutions Vision Medication Management Systems, Inc. (MMS) envisions a health care system in which all patients
More informationPractice Spotlight. Florida Hospital Orlando Orlando, FL www.floridahospital.com IN YOUR VIEW, HOW WOULD YOU DEFINE THE IDEAL PHARMACY PRACTICE MODEL?
Practice Spotlight Florida Hospital Orlando Orlando, FL www.floridahospital.com Craig Coumbe, R.Ph., M.B.A. Director of Pharmacy Rania El Lababidi, Pharm.D., BCSP (AQ ID), AAHIVP Assistant Director, Clinical
More informationSpecialty Pharmacy? Disclosure. Objectives Technician
Disclosure What s so SPECIAL about? I have no actual or potential conflict of interest in relation to this program/presentation. Michael DeCoske, PharmD, BCPS Associate Chief Pharmacy Officer Duke University
More informationStatement of Conflicts of Interest
10 th Annual 340B Coalition Winter Conference Expansion of Pharmacy Services Through the 340B Program Binita Patel, PharmD, MS Director of Ambulatory/Retail Services Froedtert & Medical College of Wisconsin
More informationDickinson Wright, PLLC 03956-006
Dickinson Wright, PLLC 03956-006 Flexible Blue SM Plan 3 Medical Coverage with Preventive Care and Mammography Benefits Benefits-at-a-Glance This is intended as an easy-to-read summary and provides only
More informationAddressing forecasted oncologist shortage: A Cancer Education Program for Pharmacy Students (CEPPS)
Addressing forecasted oncologist shortage: A Cancer Education Program for Pharmacy Students (CEPPS) Dr. Department of Pharmacy Practice State University of New York School of Pharmacy and Pharmaceutical
More information10/4/10. Risë Marie Cleland Rise@Oplinc.com
Risë Marie Cleland Rise@Oplinc.com describe trends increasing the financial risk for practices & patients, understand how financial counseling minimizes this risk identify key tasks & Best Practices in
More informationMedicare Resource Guide
Medicare Resource Guide Patient Name Dear Patient, Please take the time to read the following sections of this brochure as noted by your healthcare provider. These different components of Medicare deal
More informationPatient Assistance Program Primer
Patient Assistance Program Primer Suzanne Lepage Private Health Plan Strategist Suzanne Lepage Consulting Inc. Kitchener, Ontario The opinions expressed in this presentation are those of the speaker. The
More informationEvaluating the impact of REMS on burden and patient access
Evaluating the impact of REMS on burden and patient access Doris Auth, Pharm.D. Team Leader, Division of Risk Management Office of Medication Error Prevention and Risk Management Center for Drug Evaluation
More informationTraditional Pharmacy Management Versus Oncology Pharmacy Management:
Traditional Pharmacy Management Versus Oncology Pharmacy Management: Analyzing the Similarities and the Differences David G. Frame, PharmD Hematology/Oncology and Bone Marrow Specialist University of Michigan
More informationMultiple sclerosis and health insurance: How to choose a plan that is right for you
Multiple sclerosis and health insurance: How to choose a plan that is right for you What are the different types of health insurance? Choosing a health insurance plan is important, especially if you have
More informationBristol-Myers Squibb Access Support Program. What Medications does the BMS Access Support Program help with? Program Registration Steps
Oncology Reimbursement Support Phone: 1-800-861-0048 Fax: 1-888-776-2370 Bristol-Myers Squibb Access Support Program The Bristol-Myers Squibb Access Support Program is designed to help patients with reimbursement
More informationENGAGING PHARMACISTS IN 1305
ENGAGING PHARMACISTS IN 1305 UTAH EXAMPLES NICOLE BISSONETTE, MPH, MCHES EPICC PROGRAM MANAGER UTAH PROJECTS INVOLVING PHARMACISTS Prior to 1305 Select Health Pharmacist Hypertension Management Team Based
More informationmedication errors at
SYMPOSIUM Chemotherapy-related medication errors A continuous-improvement approach for reducing the number of chemotherapy-related medication errors BARRY R. GOLDSPIEL, ROBERT DECHRISTOFORO, AND CHARLES
More informationNorthwest Georgia Oncology Centers, P.C.
Northwest Georgia Oncology Centers, P.C. High Deductibles and Out of Pocket HSA/HRA Plans (No up front collection) Medicare Advantage Plans Healthcare Exchange Plans Medicare only Cobra plans/high premiums
More informationOncology Medical Home Measure Specification Data
Oncology Medical Home Measure Specification Data Measure Name Chemotherapy pathway compliance Measure # 1 Measure Description % of chemotherapy treatments that have adhered to NCCN guidelines or pathways.
More informationDriving Patient Safety and Pharmacy Efficiency
CASE STUDY Driving Patient Safety and Pharmacy Efficiency Sterile Compounding, Error Reduction and Workflow Management at Indiana University Health Bloomington Hospital Steve I am totally sold on the benefits
More informationNOVARTIS SERVICE REQUEST FORM FOR PATIENT SUPPORT
NOVARTIS SERVICE REQUEST FORM FOR PATIENT SUPPORT Please complete the Fax Cover Sheet and Service Request Form, and fax all pages to the number specified below. Dear Health Care Professional: The Novartis
More informationMake sure you re covered for your biologic medicine!
It s open enrollment time Make sure you re covered for your biologic medicine! Joint Decisions is brought to you by Janssen Biotech, Inc., in partnership with CreakyJoints CreakyJoints Bringing arthritis
More informationEssentials Rx 15 (HMO) Plan offered by PacificSource Medicare. Annual Notice of Changes for 2014
Essentials Rx 15 (HMO) Plan offered by PacificSource Medicare Annual Notice of Changes for 2014 You are currently enrolled as a member of Essentials Rx 15 (HMO) Plan. Next year, there will be some changes
More informationFlexible Blue SM Plan 2 Medical Coverage with Flexible Blue SM RX Prescription Drugs Benefits-at-a-Glance for Western Michigan Health Insurance Pool
Flexible Blue SM Plan 2 Medical Coverage with Flexible Blue SM RX Prescription Drugs Benefits-at-a-Glance for Western Michigan Health Insurance Pool The information in this document is based on BCBSM s
More informationTips, Tricks and Traps Practical Insights into 340B
Tips, Tricks and Traps Practical Insights into 340B Assessing the Opportunity in Ambulatory and Specialty Pharmacy Kevin Scheckelhoff, RPh, MBA Asst. Vice President 340B Solutions, McKesson Chris Shain,
More information1/22/14. Surviving the EMR While Maintaining Excellence in Oncology Practice. Objectives THE EMR MEANINGFUL USE AND PRODUCTIVITY MEASURES
Surviving the EMR While Maintaining Excellence in Oncology Practice Wendy Andrews, BS, Practice Manager Christopher Campen, PharmD, BCPS, BCOP Sandra Kurtin, RN, MS, AOCN, ANP-C The University of Arizona
More informationIntroduction. Plan sponsors include employers, unions, trust funds, associations and government agencies, and are also referred to as payors.
Maintaining the Affordability of the Prescription Drug Benefit: How Managed Care Organizations Secure Price Concessions from Pharmaceutical Manufacturers Introduction The purpose of this paper is to explain
More informationUtilizing Pharmacy Technicians for Medication Reconciliation. Kristy Malacos, MS, CPhT Magruder Hospital Port Clinton, OH Pharmacy Systems, Inc.
Utilizing Pharmacy Technicians for Medication Reconciliation Kristy Malacos, MS, CPhT Magruder Hospital Port Clinton, OH Pharmacy Systems, Inc. Magruder Hospital Located on the shores of Lake Erie in Port
More informationBuilding a Specialty Pharmacy Business. Kyle Skiermont, PharmD Director of Specialty/Infusion Operation Fairview Pharmacy Services
Building a Specialty Pharmacy Business Kyle Skiermont, PharmD Director of Specialty/Infusion Operation Fairview Pharmacy Services Overview Agenda Brief overview of Fairview Barriers for hospital/health
More informationS c h o o l s I n s u r a n c e G r o u p Health Net Plan Comparison Fiscal Year 7/1/14-6/30/15
S c h o o l s I n s u r a n c e G r o u p Health Net Plan Comparison Fiscal Year 7/1/14-6/30/15 This information sheet is for reference only. Please refer to Evidence of Coverage requirements, limitations
More information2011 Midyear Clinical Meeting New Orleans, Louisiana. Educational Session Abstract
MCS-1 Title: Securing and managing prior authorizations for high-cost infusions in a large integrated health system Purpose: Medications administered by intravenous infusion commonly include chemotherapy,
More informationPiedmont WellStar Medicare Choice (HMO) offered by Piedmont WellStar HealthPlans, Inc.
Piedmont WellStar Medicare Choice (HMO) offered by Piedmont WellStar HealthPlans, Inc. Annual Notice of Changes for 2015 You are currently enrolled as a member of Piedmont WellStar Medicare Choice HMO.
More informationLean Six Sigma: Redesigning the Cancer Care Delivery Process. 2014 Community Oncology Conference
Lean Six Sigma: Redesigning the Cancer Care Delivery Process 2014 Community Oncology Conference Disclosure Medical Directorship, The US Oncology Network, compensated A Typical Oncology Clinic (Does this
More informationCosts Associated with Neutropenia in Elderly Patients Treated First-Line for Advanced Non-Small Cell Lung Cancer
Costs Associated with Neutropenia in Elderly Patients Treated First-Line for Advanced Non-Small Cell Lung Cancer Michael Stokes United BioSource Corporation ISPOR 13 th Annual International Meeting Toronto,
More informationFREE ANSWER ONLINE FOR INSTANT RESULTS AT WWW.CANADIANHEALTHCARENETWORK.CA SEPTEMBER 2015. by Sanna Pellatt, BSc(Pharm) Learning objectives
FONT: HELVETICA NEUE 75 BOLD (MODIFIED) CYAN 50,YELLOW 100 MAGENTA 100 CYAN 100 Continuing Education THE NATIONAL CONTINUING EDUCATION PROGRAM FOR PHARMACY TECHNICIANS 1.25 CEUs FREE ANSWER ONLINE FOR
More informationMedical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11
Effective Date: 09/12/06, 08/02/10, 3/2/11 Title: 1.0 OBJECTIVE: 1.1 This SOP describes the methods and policies for: Handling investigational drug Dispensing investigational drug 1.2. This procedure applies
More informationExceptions and Appeals for Drug Therapies: A Guide for Healthcare Providers
Exceptions and Appeals for Drug Therapies: A Guide for Healthcare Providers Table of Contents Introduction... 5 Prior Authorization... 7 Overview... 7 Step Therapy... 7 Quantity Limits... 7 The Prior Authorization
More informationUnitedHealthcare Injectable Chemotherapy Prior Authorization (PA) Program Frequently Asked Questions
UnitedHealthcare Injectable Chemotherapy Prior Authorization (PA) Program Frequently Asked Questions Q1. What members are impacted by the UnitedHealthcare Injectable Chemotherapy PA Program? A. Beginning
More informationThe University of North Carolina Wilmington PHARMACY TECHNICIAN COMPETENCY PROFILE
The University of North Carolina Wilmington PHARMACY TECHNICIAN COMPETENCY PROFILE Description of Work: Positions in this banded class assist pharmacists in providing technical pharmacy services by processing,
More informationPharmacy and Therapeutics Committee Policies and Procedures
Pharmacy and Therapeutics Committee Policies and Procedures I. Charter... p 2 II. Formulary Principles... p 3 III. Drug Review Process... p 4 7 A. When are Medications Reviewed B. How Are Medications Reviewed
More informationRemove Access Barriers and Maximize Product Uptake with an Integrated Hub Model Approach
Remove Access Barriers and Maximize Product Uptake with an Integrated Hub Model Approach When it comes to supporting the clinical and marketing objectives of any pharmaceutical franchise, helping to remove
More informationIs it time for a new drug development paradigm?
Is it time for a new drug development paradigm? Robert McDonough, M.D. Senior Director, Clinical Policy Research and Development 1 The Aetna Way Our Cause To make quality health care more affordable and
More informationUniversity of Louisville Hospital PGY1 Pharmacy Residency Program Summary
University of Louisville Hospital PGY1 Pharmacy Residency Program Summary Positions Available: 4 positions, 12 month contract Application Deadline: Early January (see PhORCAS) Requirements: On-site Interview,
More informationS c h o o l s I n s u r a n c e G r o u p Health Net Plan Comparison Fiscal Year 7/1/15-6/30/16
S c h o o l s I n s u r a n c e G r o u p Health Net Plan Comparison Fiscal Year 7/1/15-6/30/16 This information sheet is for reference only. Please refer to Evidence of Coverage requirements, limitations
More informationImplementing an Evidence Based Hospital Discharge Process
Implementing an Evidence Based Hospital Discharge Process Learning from the experience of Project Re-Engineered Discharge (RED) Webinar January 14, 2013 Chris Manasseh, MD Director, Boston HealthNet Inpatient
More informationAnnual Notice of Changes for 2015
First Health Part D Value Plus (PDP) Plan offered by First Health Life & Health Insurance Company Annual Notice of Changes for 2015 You are currently enrolled as a member of First Health Part D Essentials
More informationImplementation of a chemotherapy prescribing training programme
Implementation of a chemotherapy prescribing training programme Kumud Kantilal Macmillan Principal Network Pharmacist, Lead for Education & Training kumud.kantilal@gstt.nhs.uk Contents Page 2 Background
More informationYou have from October 15 until December 7 to make changes to your Medicare coverage for next year.
Advantra Gold (HMO) offered by HealthAmerica Pennsylvania, Inc. Annual Notice of Changes for You are currently enrolled as a member of Advantra Gold (HMO). Next year, there will be some changes to the
More informationTitle/Description: Discharge Medication Planning, Education, and Procurement
University of Kentucky / UK HealthCare Policy and Procedure Policy # A02-030 Title/Description: Discharge Medication Planning, Education, and Procurement Purpose: To educate patients discharged from UK
More informationEMR Systems and the Conduct of Clinical Research. Daniel E Ford, MD, MPH Vice Dean for Clinical Investigation Johns Hopkins School of Medicine
EMR Systems and the Conduct of Clinical Research Daniel E Ford, MD, MPH Vice Dean for Clinical Investigation Johns Hopkins School of Medicine Clinical Research Environment Research protocols are becoming
More informationU.S. Bureau of Labor Statistics. Pharmacy Tech
From the: U.S. Bureau of Labor Statistics Pharmacy Tech Pharmacy technicians fill prescriptions and check inventory. Pharmacy technicians help licensed pharmacists dispense prescription medication. They
More informationSchedule of Benefits Summary. Health Plan. Out-of-network Provider
Schedule of Benefits Summary University Name: University of Nebraska - Student Plan Health Plan : 2014/2015 Academic Year (see attached) Payment for Services Covered Services are reimbursed based on the
More informationOverview of the BCBSRI Prescription Management Program
Definitions Overview of the BCBSRI Prescription Management Program DISPENSING GUIDELINES mean: the prescription order or refill must be limited to the quantities authorized by your doctor not to exceed
More informationMaking Sense of Medicare Advantage and Part D Open Enrollment
Making Sense of Medicare Advantage and Part D Open Enrollment By Stephen L. Cohen, MD Austell, GA About this presentation: We know that a lot of material is presented here. Please go to www.medicaredrugsavings.org
More informationImplementing an RN Protocol for Uncomplicated Hypertension
RN Hypertension Protocol Joyce Cheung, RN KP, Orange County Karen Sielbeck, RN KP, South Bay Noshin Afrookhteh, RN KP, Orange County Implementing an RN Protocol for Uncomplicated Hypertension Protocol
More informationHow Independent Pharmacies Can Use Medicare Star Ratings to Improve Their Businesses
How Independent Pharmacies Can Use Medicare Star Ratings to Improve Their Businesses We are in a new, changing healthcare environment that is affecting every stakeholder in the market hospitals, doctors,
More informationCreating a Hospital Based Bedside Delivery Program to Enhance the Patient Experience at Cleveland Clinic s Community Hospitals
Learning Objectives Creating a Hospital Based Bedside Delivery Program to Enhance the Patient Experience at Cleveland Clinic s Community Hospitals Describe the 5 steps needed to create an effective hospital
More informationSchedule of Benefits. Plan Information Participating Provider Non-Participating Provider
Schedule of Benefits UPMC Consumer Advantage HSA PPO - Premium Network Primary Care Provider: 10% after Deductible Specialist: 10% after Deductible Deductible: $1,950 / $3,900 Rx: 10% after Deductible
More informationHow To Educate Nursing Staff On Medication Reconciliation, Nurse Education, And
Advancing Medication Reconciliation in an Outpatient Internal Medicine Clinic through a Pharmacist-Led Educational Initiative Sarah M. Westberg, Pharm.D. 1 and Kathrine Beeksma, R.N. 2 1 College of Pharmacy
More informationThese are just some of the eligibility requirements meeting these criteria does not guarantee acceptance.
BARACLUDE PATIENT ASSISTANCE PROGRAM The Baraclude Patient Assistance Program is designed to provide free medication to qualifying patients who do not have prescription drug coverage and are having a hard
More informationAnnual Notice of Changes for 2014
First Health Part D Premier Plus (PDP) offered by Cambridge Life Insurance Company Annual Notice of Changes for 2014 Dear Member, You are currently enrolled as a member of First Health Part D Premier Plus
More informationACS CAN Examination of Cancer Drug Coverage and Transparency in the Health Insurance Marketplaces
ACS CAN Examination of Cancer Drug Coverage and Transparency in the Health Insurance Marketplaces Executive Summary November 18, 2015 In 2014, the American Cancer Society Cancer Action Network (ACS CAN)
More informationAnnual Notice of Changes for 2014
Blue Medicare HMO SM Standard offered by Blue Cross and Blue Shield of North Carolina (BCBSNC) Annual Notice of Changes for 2014 You are currently enrolled as a member of Blue Medicare HMO Standard. Next
More informationArthritis Foundation Position Statement on Biosimilar Substitution
Arthritis Foundation Position Statement on Biosimilar Substitution The Affordable Care Act creates a regulatory pathway for the approval of a new generation of biologic medications called biosimilars.
More informationPRINCIPAL DEPUTY ADMINISTRATOR, DEPUTY ADMINISTRATOR FOR INNOVATION AND QUALITY, AND CHIEF MEDICAL OFFICER, CENTERS FOR MEDICARE & MEDICAID SERVICES
STATEMENT OF PATRICK CONWAY, MD, MSc ACTING PRINCIPAL DEPUTY ADMINISTRATOR, DEPUTY ADMINISTRATOR FOR INNOVATION AND QUALITY, AND CHIEF MEDICAL OFFICER, CENTERS FOR MEDICARE & MEDICAID SERVICES ON EXAMINING
More informationYour Retiree Health Care Travel Guide
SPECIAL EDITION for Individuals Not Yet Eligible for Medicare Your Retiree Health Care Travel Guide 2010 Enrollment for BorgWarner Pre-Medicare Health Care Coverage Welcome to 2010 Pre-Medicare enrollment!
More informationNOVARTIS SERVICE REQUEST FORM FOR PATIENT SUPPORT
NOVARTIS SERVICE REQUEST FORM FOR PATIENT SUPPORT Please complete the Fax Cover Sheet and Service Request Form, and fax all pages to the number specified below. Dear Health Care Professional: The Novartis
More informationOPTIMIZING THE USE OF YOUR ELECTRONIC HEALTH RECORD. A collaborative training offered by Highmark and the Pittsburgh Regional Health Initiative
OPTIMIZING THE USE OF YOUR ELECTRONIC HEALTH RECORD A collaborative training offered by Highmark and the Pittsburgh Regional Health Initiative Introductions Disclosures Successful completion of training
More informationANNUAL NOTICE OF CHANGES FOR 2016
Cigna-HealthSpring Preferred (HMO) offered by Cigna-HealthSpring ANNUAL NOTICE OF CHANGES FOR 2016 You are currently enrolled as a member of Cigna-HealthSpring Preferred (HMO). Next year, there will be
More information2014 Prescription Drug Schedule Humana Medicare Employer Plan
2014 Prescription Drug Schedule Humana Medicare Employer Plan Option 98 City of Newport News Y0040_GHHHEF3HH14 SECTION I - INTRODUCTION TO SUMMARY OF BENEFITS Thank you for your interest in the Humana
More informationIncreasing Patient Access through Oral Parity Legislation
Increasing Patient Access through Oral Parity Legislation The Leukemia & Lymphoma Society A powerhouse among nonprofits searching for cancer cures Our Mission; Cure leukemia, lymphoma, Hodgkin s disease
More informationAnnual Notice of Changes for 2015
Coventry Advantage (no drug) (HMO) offered by Coventry Health Care of Missouri, Inc. Annual Notice of Changes for 2015 You are currently enrolled as a member of Coventry Advantage (no drug) (HMO). Next
More informationLos Rios Community College District KAISER PERMANENTE
Los Rios Community College District KAISER PERMANENTE GROUP # 602838: Early Retiree DHMO Plan (under age 65 or over 65 w/o Medicare A & B) Senior Advantage (age 65+ with Medicare A & B) In order to continue
More informationAnnual Notice of Changes for 2016
Upper Peninsula Health Plan Advantage (HMO) offered by Upper Peninsula Health Plan, LLC Annual Notice of Changes for 2016 You are currently enrolled as a member of Upper Peninsula Health Plan Advantage
More informationCASE STUDY. Spencer Hospital, Iowa Advanced Technician Practice Model Tech check Tech (TCT)
Spencer Hospital, Iowa Advanced Technician Practice Model Tech check Tech (TCT) Submitted By: Gayle Mayer, RPh, BPharm, Director of Pharmacy Spencer Hospital Pharmacy Staff Primary Intended Outcome(s):
More informationUsing Medicare s Website to Choose a Medicare-Approved Drug Plan 2016. Prepared by Senior PharmAssist (rev 10.07.2015)
TIPS AND HINTS: Using Medicare s Website to Choose a Medicare-Approved Drug Plan 2016 Prepared by Senior PharmAssist (rev 10.07.2015) IT PAYS TO COMPARE. The plan that was the cheapest for you in 2015
More informationAnnual Notice of Changes for 2014
Advocare Spirit Rx (HMO-POS) offered by Security Health Plan of Wisconsin, Inc. Annual Notice of Changes for 2014 You are currently enrolled as a member of Advocare Spirit Rx (HMO-POS). Next year there
More informationReal-time Pre and Post Claim Edits: Improve Reimbursement, Compliance and Safety
Real-time Pre and Post Claim Edits: Improve Reimbursement, Compliance and Safety An ESI Healthcare Business Solutions White Paper by Thomas Renshaw R.Ph. Introduction Outpatient pharmacies submitting claims
More informationTerms Defined. Participating/Non-Participating Provider. Benefits Coverage Charts. Prescription Drug Purchases. Pre-Authorization
Medical Coverage Terms Defined Participating/Non-Participating Provider Benefits Coverage Charts Prescription Drug Purchases Section Two MEDICAL COVERAGE Pre-Authorization Coordination of Benefits Questions
More informationUnderstanding Your Health Insurance Plan
Understanding Your Health Insurance Plan Slide Catalog for Assisters Updated May 6, 2015 Health Insurance Costs Terms to Know: Premium Premium: The monthly bill you pay to your health insurance company.
More informationTHE 2013 GENENTECH ONCOLOGY TREND REPORT
THE 2013 GENENTECH ONCOLOGY TREND REPORT Perspectives From Managed Care, Specialty Pharmacy Providers, Oncologists, Practice Managers, and Employers 2013 Genentech, South San Francisco, CA December 2013
More informationMAPD-SNP Contract Numbers: H5852; H3132
Policy and Procedure No: 93608 PHP Transition Process Title: Part D Transition Process Department: Pharmacy Services, Managed Care Effective Date: 1/1/2006 Supercedes Policy No: PH 8.0 Reviewed/Revised
More informationInsurance Exchanges: New Market Opportunities & Threats to Access. February 2014 avalerehealth.net
Insurance Exchanges: New Market Opportunities & Threats to Access February 2014 avalerehealth.net Despite Slow Initial Enrollment, Exchange Participation Is Accelerating Most Sign-Ups Expected Close to
More informationClinical Safety & Effectiveness Session # 11
Clinical Safety & Effectiveness Session # 11 Clinical Staff Competency Training DATE Educating for Quality Improvement & Patient Safety 1 Division The Team CS & E Participant - Carlayne Jackson, MD CS
More informationStatement Of. The National Association of Chain Drug Stores. For. U.S. Senate Special Committee on Aging. Hearing on:
Statement Of The National Association of Chain Drug Stores For U.S. Senate Special Committee on Aging Hearing on: 10 Years Later: A Look at the Medicare Prescription Drug Program 2:30 p.m. 366 Dirksen
More informationConflict of Interest Disclosure
Leveraging Clinical Decision Support for Optimal Medication Management Anne M Bobb, BS Pharm., Director Quality Informatics Children s Memorial Hospital, Chicago IL, February 20, 2012 DISCLAIMER: The views
More informationThe Impact of Palliative Care and Hospice Services in the Care of Patients with Advanced Stage Non-Small Cell Lung Cancer
The Impact of Palliative Care and Hospice Services in the Care of Patients with Advanced Stage Non-Small Cell Lung Cancer Richard C. Stephenson, MD Hospice & Palliative CareCenter Amy H. Hughes Forsyth
More informationANNUAL NOTICE OF CHANGES FOR 2016
Cigna-HealthSpring Preferred (HMO) offered by Cigna-HealthSpring ANNUAL NOTICE OF CHANGES FOR 2016 You are currently enrolled as a member of Cigna-HealthSpring Preferred (HMO). Next year, there will be
More information2015 Annual Convention
2015 Annual Convention Date: Tuesday, October 13, 2015 Time: 11:30 am 1:00 pm Location: Gaylord National Harbor Resort and Convention Center, National Harbor 11 Title: Activity Type: Speaker: Managing
More information